Liu, W. W., Shalaby, W. S., Shiuey, E. J., Raghu, R., Petkovsek, D., Myers, J. S., Wizov, S. S., Spaeth, G. L., & Shukla, A. G. (2023). Correlation between Central Visual Field Defects and Stereopsis in Patients with Early-to-Moderate Visual Field Loss. Ophthalmology Glaucoma, 6(5), 493–500. https://doi.org/10.1016/j.ogla.2023.04.003

McBride, R. B., Suarez-Farinas, M., Ko, H. M., Chen, X., Liu, Q., & Harpaz, N. (2023). Density of Biopsy Sampling Required to Ensure Accurate Histological Assessment of Inflammation in Active Ulcerative Colitis. Inflammatory Bowel Diseases, 29(11), 1706–1712. https://doi.org/10.1093/ibd/izad063

Topping, R. P., Quill, T. A., Lamanna, N., & Sharman, J. P. (2023). Determining Clinical Practice Gaps for HCPs in Treating CLL Using CME-Based Surveys. Blood, 142(Supplement 1), 3716–3716. https://doi.org/10.1182/blood-2023-190329

Varkaris, A., Pazolli, E., Gunaydin, H., Wang, Q., Pierce, L., Boezio, A. A., Bulku, A., DiPietro, L., Fridrich, C., Frost, A., Giordanetto, F., Hamilton, E. P., Harris, K., Holliday, M., Hunter, T. L., Iskandar, A., Ji, Y., Larivée, A., LaRochelle, J. R., … Kipp, D. R. (2023). Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia. Cancer Discovery, 14(2), 240–257. https://doi.org/10.1158/2159-8290.cd-23-0944

Fahmy, L. M., Yang, H. R., Zhou, M., Beylergil, V., Schreidah, C. M., Bilgrami, Z., Kwinta, B. D., Schwartz, L., Fojo, A. T., Bates, S. E., & Geskin, L. J. (2023). Dynamic Changes in Lymph Node Size and Skin Scoring Predict Response to Treatment in CTCL: An Interim Analysis. Blood, 142(Supplement 1), 4443–4443. https://doi.org/10.1182/blood-2023-189493

Azar, M., Chapman, S., Joyce, J., Schultheis, M., Zhang, Z., Waltrip, L., Shagalow, S., Zeiger, P., Sunderaraman, P., & Cosentino, S. (2023). Education as a Moderator of Help Seeking Behavior in Subjective Cognitive Decline. Alzheimer Disease & Associated Disorders, 37(3), 184–188. https://doi.org/10.1097/wad.0000000000000571

Kalibala, D., Nabaggala, C., Turyagyenda, L., Mboizi, V., Naggayi, S. K., Kabatabaazi, M., Rosano, C., Munube, D., Kasirye, P., Ssenkusu, J., Opoka, R., Bangirana, P., Green, N. S., Idro, R., & Mupere, E. (2023). Effect of Hydroxyurea Treatment on Body Composition in Children with Sickle Cell Anemia in Uganda Using Bioelectrical Impedance Analysis (BIA). Blood, 142(Supplement 1), 1136–1136. https://doi.org/10.1182/blood-2023-190181

De, A., Jung, K. hwa, Davis, H., Siddiqui, A., Kattan, M., Quinn, J., Rundle, A. G., Lovinsky-Desir, S., & Green, N. S. (2023). Effects of Air Pollution on Respiratory Events and Pain Crises Among Children with Sickle Cell Disease in New York City. Blood, 142(Supplement 1), 5298–5298. https://doi.org/10.1182/blood-2023-189540

Dhodapkar, M. V., Alsina, M., Berdeja, J. G., Patel, K. K., Richard, S., Vij, R., Leleu, X., Egan, D. N., Bergsagel, P. L., Reshef, R., Usmani, S. Z., Truppel-Hartmann, A., Basudhar, D., Thompson, E., Zheng, X., Eliason, L., Zhong, X., Greggio, C., Tran, S., … Siegel, D. S. (2023). Efficacy and Safety of Idecabtagene Vicleucel (ide-cel) in Patients with Clinical High-Risk Newly Diagnosed Multiple Myeloma (NDMM) with an Inadequate Response to Frontline Autologous Stem Cell Transplantation (ASCT): KarMMa-2 Cohort 2c Extended Follow-up. Blood, 142(Supplement 1), 2101–2101. https://doi.org/10.1182/blood-2023-173970

Tashi, T., Hermine, O., Castells, M., Guilarte, M., Sabato, V., Maurer, M., Panse, J., Alvarez-Twose, I., Cabral, R., Bird, R., Barete, S., Bouillet, L., Hermans, M., Van Daele, P., González-De-Olano, D., Griffiths, E. A., Jurcic, J., Dybedal, I., Damaj, G. L., … Livideanu, C. B. (2023). Elenestinib, an Investigational, Next Generation KIT D816V Inhibitor, Reduces Mast Cell Burden, Improves Symptoms, and Has a Favorable Safety Profile in Patients with Indolent Systemic Mastocytosis: Analysis of the Harbor Trial. Blood, 142(Supplement 1), 76–76. https://doi.org/10.1182/blood-2023-188904

Hughes, M. S., Leng, S., Chakraborty, R., Bhutani, D., Mapara, M., Raza, S., & Lentzsch, S. (2023). Excellent PFS and OS of Newly Diagnosed Multiple Myeloma Patients Receiving Carfilzomib, Bendamustine, and Dexamethasone (KBD): A 6.5 Year Follow-up. Blood, 142(Supplement 1), 6576–6576. https://doi.org/10.1182/blood-2023-182842

Pazos, M., Estrella, B., Piorczynski, T. B., Tolu, S. S., Huang, W., Ryu, Y. K., & Amengual, J. E. (2023). First-in-Class HAT Activator (YF2) Combined with JAK/STAT Inhibitor (ruxolitinib) Unveils Potential Novel Treatment Approach for HDAC Inhibitor-Resistant CTCL. Blood, 142(Supplement 1), 4184–4184. https://doi.org/10.1182/blood-2023-186639

Akahoshi, Y., Spyrou, N., Weber, D., Aguayo-Hiraldo, P., Ayuk, F. A., Bunworasate, U., Choe, H., Eder, M., Etra, A., Grupp, S., Hexner, E. O., Hogan, W. J., Kitko, C. L., Kraus, S., Merli, P., Qayed, M., Reshef, R., Schechter-Finkelstein, T., Ullrich, E., … Nakamura, R. (2023). Flares of Acute Graft-Versus-Host Disease: Mount Sinai Acute Gvhd International Consortium (MAGIC) Study. Blood, 142(Supplement 1), 776–776. https://doi.org/10.1182/blood-2023-181900

Kim, T. O., Geris, J. M., Grimes, A. B., Grace, R. F., Lambert, M. P., Rose, M. J., Shimano, K. A., Niss, O., Neunert, C., Nakano, T. A., Macmath, D., Dinu, B., Kirk, S. E., Despotovic, J. M., Flanagan, J. M., & Scheurer, M. E. (2023). Genetic Variants in Canonical Wnt Signaling Pathway Associated with Pediatric ITP. Blood, 142(Supplement 1), 2593–2593. https://doi.org/10.1182/blood-2023-175013

Michel, L., & Chudnoff, S. (2023). Gynecology Resident Experience with Office Hysteroscopy Training. JSLS : Journal of the Society of Laparoscopic & Robotic Surgeons, 27(2), e2023.00009. https://doi.org/10.4293/jsls.2023.00009

Green, N. S., Manwani, D., Aygun, B., Appiah-Kubi, A., Smith-Whitley, K., Jia, H., & Smaldone, A. (2023). Habit Efficacy Trial: A Multi-Site Randomized Controlled Trial of Community Health Worker Support to Increase Hydroxyurea Adherence of Youth with Sickle Cell Disease. Blood, 142(Supplement 1), 3901–3901. https://doi.org/10.1182/blood-2023-190031

Murdock, M. E., Cruz, G. J., Derby, L., Ellis, J., Kronish, I. M., Edmondson, D., & Birk, J. L. (2024). Health insurance, perceived threat, and posttraumatic stress after suspected acute coronary syndrome. Health Psychology, 43(1), 34–40. https://doi.org/10.1037/hea0001321

Hoffman, J. E., Bumma, N., Richter, J., Dhodapkar, M. V., Lee, H. C., Suvannasankha, A., Houde, C. A., Maly, J. J., Shah, M. R., Baz, R., Namburi, S., Wu, K. L., Pianko, M., Ye, J. C., Lentzsch, S., Silbermann, R., Min, C.-K., Vekemans, M.-C., Munder, M., … Jagannath, S. (2023). Health-Related Quality of Life (HRQoL) Among Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Linvoseltamab in Linker-MM1: Interim Assessment up to 36 Weeks of Treatment. Blood, 142(Supplement 1), 3359–3359. https://doi.org/10.1182/blood-2023-179170

Muchtar, E., Palladini, G., Schonland, S., Dispenzieri, A., Wisniowski, B., Merlini, G., Milani, P., Hegenbart, U., Dittrich, T., Kastritis, E., Dimopoulos, M. A., Sanchorawala, V., Szalat, R. E., Liedtke, M., Gupta, M., Landau, H., Lentzsch, S., Hughes, M. S., Cibeira López, M. T., … Gertz, M. A. (2023). Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study. Blood, 142(Supplement 1), 3411–3411. https://doi.org/10.1182/blood-2023-190226

Khatiwada, P., Soni, M., & Muranski, P. (2023). Highly Active Cytotoxic CD4 + T Cells Targeting EBV Oncoproteins with Enhanced In Vivo Anti-Tumor and Self-Renewal Properties. Blood, 142(Supplement 1), 3464–3464. https://doi.org/10.1182/blood-2023-190690

Garcia, D. R., Fletcher, J., Goldsamt, L., Bell, D. L., Zheng, Y., & Dunn Navarra, A.-M. (2023). HIV Syndemic Factor Associations Among Adolescent Gay and Bisexual Men in the Youth Risk Behavior Survey 2015–2019: A Secondary Data Analysis. Journal of the Association of Nurses in AIDS Care, 34(5), 440–458. https://doi.org/10.1097/jnc.0000000000000423

Benner, S. E., Zhu, X., Hussain, S., Florman, S., Eby, Y., Fernandez, R. E., Ostrander, D., Rana, M., Ottmann, S., Hand, J., Price, J. C., Pereira, M. R., Wojciechowski, D., Simkins, J., Stosor, V., Mehta, S. A., Aslam, S., Malinis, M., Haidar, G., … Tobian, A. A. R. (2023). HIV-Positive Liver Transplant Does not Alter the Latent Viral Reservoir in Recipients With Antiretroviral Therapy-Suppressed HIV. The Journal of Infectious Diseases, 228(9), 1274–1279. https://doi.org/10.1093/infdis/jiad241

Moorthy, T., Nguyen, H., Chen, Y., Austin, J., Smoller, J. W., Hercher, L., & Sabatello, M. (2023). How do experts in psychiatric genetics view the clinical utility of polygenic risk scores for schizophrenia? American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 192(7–8), 161–170. Portico. https://doi.org/10.1002/ajmg.b.32939

Vander Haar, E., Abshier Ware, C., Allen, G., Armstrong, R., Black, D., Bombara, M., Dhanraj, D., Lawrence, L., Miller, R., Nanda, S., Paidas, M. J., Patki, K. C., Sitras, V., Skupski, D., Swarup, M., Thorp, J., Tiller, H., Verweij, J., & Bussel, J. B. (2023). Identifying Pregnancies at Higher Risk for HPA-1a Alloimmunization and Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT): An International, Prospective, Natural History Study. Blood, 142(Supplement 1), 1224–1224. https://doi.org/10.1182/blood-2023-177657

Sebastian, T., Gu, W., Iurcotta, T., & Brachio, S. S. (2023). Improving access to neurodevelopmental resources for NICU graduates. Journal of Perinatology, 44(4), 578–580. https://doi.org/10.1038/s41372-023-01819-w

Chanbour, H., Tang, A. R., Steinle, A. M., Jonzzon, S., Roth, S. G., Gardocki, R. J., Stephens, B. F., Abtahi, A. M., & Zuckerman, S. L. (2023). In Reply: Transforaminal Lumbar Interbody Fusion Versus Posterolateral Fusion Alone in the Treatment of Grade 1 Degenerative Spondylolisthesis. Neurosurgery, 94(1), e15–e16. https://doi.org/10.1227/neu.0000000000002747

Al Malki, M. M., Keyzner, A., Suh, H. C., Matin, A., Buonomo, E., Wang, Y., Abelowitz, N., Murray, J., Macbeath, G., Barton, D., Chattopadhyay, S., & Reshef, R. (2023). Initial Results of a Phase 1 Trial of TSC-100 and TSC-101, Engineered T Cell Therapies That Target Minor Histocompatibility Antigens to Prevent Relapse after Allogeneic Hematopoietic Cell Transplantation. Blood, 142(Supplement 1), 2090–2090. https://doi.org/10.1182/blood-2023-187355

Franzova, E., Shen, Q., Doyle, K., Chen, J. M., Egbebike, J., Vrosgou, A., Carmona, J. C., Grobois, L., Heinonen, G. A., Velazquez, A., Gonzales, I. J., Egawa, S., Agarwal, S., Roh, D., Park, S., Connolly, E. S., & Claassen, J. (2023). Injury patterns associated with cognitive motor dissociation. Brain, 146(11), 4645–4658. https://doi.org/10.1093/brain/awad197

Tofighi, B., Badiei, B., Badolato, R., Lewis, C. F., Nunes, E., Thomas, A., & Lee, J. D. (2023). Integrating Text Messaging in a Low Threshold Telebuprenorphine Program for New York City Residents with Opioid Use Disorder during COVID-19: A Pilot Randomized Controlled Trial. Journal of Addiction Medicine, 17(5), e281–e286. https://doi.org/10.1097/adm.0000000000001161

Sawires, A. N., Weiner, T. R., Shah, R. P., Geller, J. A., & Cooper, H. J. (2023). Is It Necessary to Wake Patients for Overnight Vital Signs Following Total Joint Arthroplasty? Orthopaedic Nursing, 42(4), 243–248. https://doi.org/10.1097/nor.0000000000000957

Tolu, S. S., Piorczynski, T. B., Pazos, M., Estrella, B., Huang, W., Ryu, Y. K., Cherng, H.-J. J., Pro, B., & Amengual, J. E. (2023). JAK1/2 Inhibition Modulates Key Markers of Lymphomagenesis in 9p24.1 Amplified Lymphoma, Priming for Enhanced Antigenicity. Blood, 142(Supplement 1), 6118–6118. https://doi.org/10.1182/blood-2023-180875

Bagot, M., Kim, Y. H., Geskin, L. J., Ortiz-Romero, P. L., Kim, E., Mehta-Shah, N., Dereure, O., Oro, S., Beylot-Barry, M., Dalle, S., Jacobsen, E., Lansigan, F., Ram-Wolff, C., Khodadoust, M. S., Battistella, M., Gru, A. A., Moins-Teisserenc, H., Zinzani, P. L., Viotti, J., … Porcu, P. (2023). Lacutamab in Patients with Relapsed and Refractory Sèzary Syndrome: Results from the Tellomak Phase 2 Trial. Blood, 142(Supplement 1), 185–185. https://doi.org/10.1182/blood-2023-173806

Williams, A. L., Abu-Bonsrah, N., Lee, R. P., Raji, O., Luciano, M., Huang, J., & Groves, M. L. (2023). Letter: The Role of Sonolucent Implants in Global Neurosurgery. Neurosurgery, 94(1), e1–e5. https://doi.org/10.1227/neu.0000000000002723

Schreidah, C. M., DeStephano, D. M., Pan, S. S., Wang, S., Shen, H., Ta, C. N., Reynolds, G. B., Fahmy, L. M., Gordon, E. R., Adeuyan, O., Kwinta, B. D., Stonesifer, C. J., Chan, W. H., Choi, J., Duvic, M., Gallardo, F., Girardi, M., Guitart, J., Kim, Y. H., … Geskin, L. J. (2023). Machine Learning-Based Survival Analysis Reveals Prognostic Clinical and Genetic Insights for Patients with Cutaneous T-Cell Lymphoma. Blood, 142(Supplement 1), 1715–1715. https://doi.org/10.1182/blood-2023-190775

Namazzi, R., Idro, R., Kalibala, D., Ssenkusu, J., Akun, P., Mboizi, V., Gondwe, T. N., Munube, D., Kasirye, P., Nabaggala, C., John, C. C., Green, N. S., Robberstat, B., Hensbroek, B. van, Kuile, F. ter, Phiri, K. S., & Opoka, R. (2023). Malaria in Children with Sickle Cell Anaemia in Areas with Low, Moderate and High Transmission in Uganda. Blood, 142(Supplement 1), 5327–5327. https://doi.org/10.1182/blood-2023-189066

Gui, G., Dillon, L. W., Ravindra, N., Hegde, P. S., Andrew, G., Mukherjee, D., Wong, Z., Auletta, J. J., El Chaer, F., Chen, E. C., Chen, Y.-B., Corner, A., Devine, S. M., Iyer, S. G., Jimenez Jimenez, A. M., de Lima, M., Litzow, M. R., Kebriaei, P., Saber, W., … Hourigan, C. S. (2023). Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia. Blood, 142(Supplement 1), 4316–4316. https://doi.org/10.1182/blood-2023-186376

Proli, A., Sawas, A., Ho, G., Wang, J., & Fullerton, C. (2023). Methods for Identification of Blood Product Transfusions in a Cohort of Myelofibrosis Patients: An Assessment of Data Capture Using Insurance Claims and Electronic Health Record Abstraction. Blood, 142(Supplement 1), 7292–7292. https://doi.org/10.1182/blood-2023-189374

Cherng, H.-J. J., Yang, X., Yancey, R., Gordillo, C. A., Piorczynski, T. B., Chan, H. T., Ofori, K. N., Bhagat, G., Califano, A., Pro, B., Booher, K., Amengual, J. E., Reshef, R., & Sina, A. A. I. (2023). Methylated Whole Genome Cell-Free DNA Sequencing before Chimeric Antigen Receptor T-Cell Therapy for Large B-Cell Lymphoma Predicts Treatment Outcomes. Blood, 142(Supplement 1), 4371–4371. https://doi.org/10.1182/blood-2023-178376

Shi, A., Ali, A. M., Cann, G., Shaknovich, R., Venn, O., Raza, A., & Liu, Q. (2023). Methylation Biology of a Blood-Based MDS Risk Stratification Test. Blood, 142(Supplement 1), 4599–4599. https://doi.org/10.1182/blood-2023-180256

Bernard, E., Hasserjian, R., Greenberg, P. L., Arango Ossa, J. E., Creignou, M., Nannya, Y., Tuechler, H., Medina-Martínez, J. S., Levine, M. F., Jädersten, M., Germing, U., Sanz, G., van de Loosdrecht, A. A., Kosmider, O., Follo, M. Y., Thol, F., Zamora, L., Pinheiro, R. F., Pellagatti, A., … Papaemmanuil, E. (2023). Molecular Taxonomy of Myelodysplastic Syndromes and Its Clinical Implications. Blood, 142(Supplement 1), 997–997. https://doi.org/10.1182/blood-2023-186863

Delgardo, M., Rabin, G., Tudor, T., Tang, A. J., Reeves, G., & Connolly, E. S. (2023). Monitoring risk and preventing ischemic stroke in the very old. Expert Review of Neurotherapeutics, 23(9), 791–801. https://doi.org/10.1080/14737175.2023.2244674

Zhao, Y., Potenza, M. N., Tapert, S. F., & Paulus, M. P. (2023). Neural correlates of negative life events and their relationships with alcohol and cannabis use initiation. Dialogues in Clinical Neuroscience, 25(1), 112–121. https://doi.org/10.1080/19585969.2023.2252437

Naggayi, S. K., Kalibala, D., Opoka, R., Rosano, C., Munube, D., Kasirye, P., Mupere, E., Mboizi, V., Ssenkusu, J., Green, N. S., Idro, R., & Bangirana, P. (2023). Neurocognitive Improvement with Hydroxyurea Therapy in Children with Sickle Cell Anemia in Uganda: Interim Analysis at Month 18. Blood, 142(Supplement 1), 275–275. https://doi.org/10.1182/blood-2023-190687

Peters, D. T., Amburn, J., Tuchman, S., Lichtman, E. I., Jensen, C. E., Jain, K., Lentzsch, S., Chakraborty, R., Bhutani, D., & Rubinstein, S. M. (2023). Outcomes Associated with Clone-Directed Therapies for Monoclonal Gammopathy of Renal Significance. Blood, 142(Supplement 1), 2027–2027. https://doi.org/10.1182/blood-2023-189341

Tolu, S. S., Sanjurjo, A., Destephano, D., Pro, B., & Amengual, J. E. (2023). Outcomes in Minorities with PTCL By Clinical Trial Enrollment. Blood, 142(Supplement 1), 4431–4431. https://doi.org/10.1182/blood-2023-177722

Tolu, S. S., Gribbin, C., Seshadri, M. R., Chen, Z., Orlando, E., Grenet, J., Toor, R., Sanjurjo, A., Phillips, A. A., Shore, T. B., Martin, P., Leonard, J. P., Pro, B., Amengual, J. E., & Ruan, J. (2023). Outcomes of Contemporary Novel Agent and Stem Cell Transplantation in Relapsed/Refractory PTCL. Blood, 142(Supplement 1), 1698–1698. https://doi.org/10.1182/blood-2023-178231

Patel, A. A., Yoon, J. J., Johnston, H., Davidson, M. B., Viswabandya, A., Shallis, R. M., Chen, E. C., Burkart, M., Oh, T. S., Iyer, S. G., Madarang, E., Muthiah, C., Dean, R., Kassner, J., Rampal, R. K., Guru Murthy, G. S., Bradley, T., Abaza, Y., Garcia, J. S., … Odenike, O. (2023). Outcomes of Patients with Accelerated/Blast-Phase MPNs That Received Allogeneic Stem-Cell Transplant in the Current Era of Myeloid Therapies. Blood, 142(Supplement 1), 3192–3192. https://doi.org/10.1182/blood-2023-174790

Coombs, C. C., Woyach, J. A., Brown, J. R., Ghia, P., Roeker, L. E., Patel, K., Eyre, T. A., Tam, C. S., Seymour, J. F., Shah, N. N., Flinn, I. W., Cheah, C. Y., Ma, S., Rhodes, J. M., Izutsu, K., Jurczak, W., Wierda, W. G., Loubert, A., Payakachat, N., … Lamanna, N. (2023). Patient-Reported Outcomes (PROs) Among Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving Pirtobrutinib: Analysis from the BRUIN Phase 1/2 Study. Blood, 142(Supplement 1), 6535–6535. https://doi.org/10.1182/blood-2023-186145

Holtan, S. G., Martens, M. J., Al Malki, M. M., Efebera, Y., Kitko, C. L., Reshef, R., Rezvani, A. R., Shaffer, B. C., Solh, M. M., Yao, J. M., Runaas, L., Elmariah, H., Larkin, K. T., El Jurdi, N. H., Gooptu, M., Loren, A. W., Hall, A. C., Alousi, A., Jamy, O., … Bolanos-Meade, J. (2023). Patient-Reported Outcomes of BMT CTN 1703: A Randomized Phase III Study for Gvhd Prophylaxis - a Quality of Life Evaluation. Blood, 142(Supplement 1), 897–897. https://doi.org/10.1182/blood-2023-187859

Jagannath, S., Richter, J., Dhodapkar, M. V., Hoffman, J. E., Lee, H. C., Suvannasankha, A., Shah, M. R., Lentzsch, S., Zonder, J. A., Baz, R., Maly, J. J., Namburi, S., Wu, K. L., Pianko, M., Ye, J. C., Silbermann, R., Min, C.-K., Vekemans, M.-C., Munder, M., … Bumma, N. (2023). Patterns of Response to 200 Mg Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma: Longer Follow-Up of the Linker-MM1 Study. Blood, 142(Supplement 1), 4746–4746. https://doi.org/10.1182/blood-2023-177968